标题
Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
作者
关键词
-
出版物
Arthritis & Rheumatology
Volume 69, Issue 2, Pages 257-267
出版商
Wiley
发表日期
2016-09-17
DOI
10.1002/art.39865
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- OP0034 The Serotonin Receptor 2 Inhibitor Terguride Has Beneficial Effects on Skin Fibrosis: Results from A Phase 2 Proof of Concept Study
- (2016) O. Distler et al. ANNALS OF THE RHEUMATIC DISEASES
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- Canonical Wnt signaling in systemic sclerosis
- (2016) Christina Bergmann et al. LABORATORY INVESTIGATION
- Tocilizumab for systemic sclerosis: implications for future trials
- (2016) Oliver Distler et al. LANCET
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- OP0266 Lysophophatidic Acid Receptor 1 Antagonist SAR100842 as a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2A Study
- (2015) Y. Allanore et al. ANNALS OF THE RHEUMATIC DISEASES
- Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
- (2015) Clara Dees et al. ANNALS OF THE RHEUMATIC DISEASES
- Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis
- (2015) Thomas Wohlfahrt et al. ANNALS OF THE RHEUMATIC DISEASES
- Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
- (2015) Jingang Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
- (2015) Mario E. Lacouture et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis
- (2015) Yangyang Luo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
- (2015) Lisa M. Rice et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma
- (2015) Pei-Suen Tsou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
- (2015) Katrin Palumbo-Zerr et al. NATURE MEDICINE
- Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
- (2015) Carmel B. Nanthakumar et al. NATURE REVIEWS DRUG DISCOVERY
- Genetics, Epigenetics, and Genomics of Systemic Sclerosis
- (2015) Gloria Salazar et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The α v β 1 integrin plays a critical in vivo role in tissue fibrosis
- (2015) Nilgun I. Reed et al. Science Translational Medicine
- A Reactive Oxygen Species-Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis
- (2015) Tatiana Spadoni et al. Arthritis & Rheumatology
- Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis
- (2014) Charlotte Rouzaud-Laborde et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model
- (2014) Lynne A. Murray et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
- (2014) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
- (2014) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
- (2014) Pawel Zerr et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- Transforming growth factor β—at the centre of systemic sclerosis
- (2014) Robert Lafyatis Nature Reviews Rheumatology
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Antiangiogenic Treatment Diminishes Renal Injury and Dysfunction via Regulation of Local AKT in Early Experimental Diabetes
- (2014) Xiaoyan Bai et al. PLoS One
- Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
- (2014) L. Hecker et al. Science Translational Medicine
- Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis
- (2014) Shinji Noda et al. Nature Communications
- The Nuclear Receptor Constitutive Androstane Receptor/NR1I3 Enhances the Profibrotic Effects of Transforming Growth Factor β and Contributes to the Development of Experimental Dermal Fibrosis
- (2014) Jérôme Avouac et al. Arthritis & Rheumatology
- NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses
- (2014) Fan Jiang et al. Redox Biology
- Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
- (2013) Britta Maurer et al. ANNALS OF THE RHEUMATIC DISEASES
- The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
- (2013) Clara Dees et al. ANNALS OF THE RHEUMATIC DISEASES
- Activation of pregnane X receptor inhibits experimental dermal fibrosis
- (2013) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
- (2013) Ning Ding et al. CELL
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
- (2013) Tamar Mchedlidze et al. IMMUNITY
- A nonclassical vitamin D receptor pathway suppresses renal fibrosis
- (2013) Ichiaki Ito et al. JOURNAL OF CLINICAL INVESTIGATION
- Endostatin inhibits hypertrophic scarring in a rabbit ear model
- (2013) Hai-tao Ren et al. Journal of Zhejiang University-SCIENCE B
- Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma
- (2013) Elizabeth E. Gerber et al. NATURE
- Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
- (2013) Neil C Henderson et al. NATURE MEDICINE
- Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
- (2013) Yun-Yan Wan et al. RESPIRATORY RESEARCH
- Brief Report: Lysyl Oxidase Is a Potential Biomarker of Fibrosis in Systemic Sclerosis
- (2013) Doron Rimar et al. Arthritis & Rheumatology
- Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
- (2012) Christian Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
- (2012) Korsa Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis
- (2012) Christian Beyer et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Epigenetic regulation of wound healing and fibrosis
- (2012) Jelena Mann et al. CURRENT OPINION IN RHEUMATOLOGY
- Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
- (2012) Akira Tokumura et al. International Journal of Medical Sciences
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- A Peptide Derived from Endostatin Ameliorates Organ Fibrosis
- (2012) Y. Yamaguchi et al. Science Translational Medicine
- Morphogen Pathways in Systemic Sclerosis
- (2012) Christian Beyer et al. Current Rheumatology Reports
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
- (2011) Flavia V. Castelino et al. ARTHRITIS AND RHEUMATISM
- Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature
- (2011) Yoav Arnson et al. AUTOIMMUNITY REVIEWS
- Conversion of Mechanical Force into TGF-β-Mediated Biochemical Signals
- (2011) Toru Maeda et al. CURRENT BIOLOGY
- Platelet-derived serotonin links vascular disease and tissue fibrosis
- (2011) Clara Dees et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
- (2011) Mohammad R Ebrahimkhani et al. NATURE MEDICINE
- Platelets, inflammation and tissue regeneration
- (2011) Alan Nurden THROMBOSIS AND HAEMOSTASIS
- Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
- (2010) G. Riemekasten et al. ANNALS OF THE RHEUMATIC DISEASES
- A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
- (2010) G. Farina et al. ARTHRITIS AND RHEUMATISM
- Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
- (2010) Sieglinde Marquart et al. ARTHRITIS AND RHEUMATISM
- Expression of integrin 1 by fibroblasts is required for tissue repair in vivo
- (2010) S. Liu et al. JOURNAL OF CELL SCIENCE
- Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5
- (2010) Yukie Yamaguchi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effect of Warfarin on Survival in Scleroderma-associated Pulmonary Arterial Hypertension (SSc-PAH) and Idiopathic PAH. Belief Elicitation for Bayesian Priors
- (2010) SINDHU R. JOHNSON et al. JOURNAL OF RHEUMATOLOGY
- Methylation determines fibroblast activation and fibrogenesis in the kidney
- (2010) Wibke Bechtel et al. NATURE MEDICINE
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- PPARγ Downregulation by TGFß in Fibroblast and Impaired Expression and Function in Systemic Sclerosis: A Novel Mechanism for Progressive Fibrogenesis
- (2010) Jun Wei et al. PLoS One
- The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
- (2009) Galina S. Bogatkevich et al. ARTHRITIS AND RHEUMATISM
- Loss of β1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model
- (2009) Shangxi Liu et al. ARTHRITIS AND RHEUMATISM
- Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor- -stimulated collagen production by cardiac fibroblasts
- (2009) N. Gellings Lowe et al. CARDIOVASCULAR RESEARCH
- Inhibition of Endostatin/Collagen XVIII Deteriorates Left Ventricular Remodeling and Heart Failure in Rat Myocardial Infarction Model
- (2009) Kazuya Isobe et al. CIRCULATION JOURNAL
- Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic Fibrosis
- (2009) Lorin E. Olson et al. DEVELOPMENTAL CELL
- Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma
- (2009) Nobuyo Higashi-Kuwata et al. EXPERIMENTAL DERMATOLOGY
- Peroxisome proliferator-activated receptor-γ abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator
- (2009) Asish K. Ghosh et al. FASEB JOURNAL
- NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
- (2009) Louise Hecker et al. NATURE MEDICINE
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
- (2008) Catherine Skhirtladze et al. ARTHRITIS AND RHEUMATISM
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
- Anti-inflammatory Renoprotective Effect of Clopidogrel and Irbesartan in Chronic Renal Injury
- (2007) X. Tu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started